Colin Fan, previously a managing partner at the investment management subsidiary overseeing the SoftBank Vision Funds, will assume an adviser position at the unit.
Author: Edison Fu
Edison Fu is a reporter and Asia liaison at Global Corporate Venturing.
Citi supports diverse founders
Clerkie, Ketos, MedHaul, Perch, Shift, Superpedestrian and Vyv have all received funding from the banking group’s $200m Impact Fund.
Rising Stars Q&A – Malin Carlström, ABB Technology Ventures
Q&A with Malin Carlström, head of ventures, ABB Electrification
Melio gets $110m payment
The American Express and Salesforce-backed billing settlement platform developer has bolstered its valuation to $1.3bn through the latest round.
Keio Innovation Initiative catches Eisai backing
KII’s Eisai-backed second fund has closed a $99.3m second fund more than double the size of its predecessor, which closed at $43m five years ago.
Miinto mints new round
The RTL Ventures-backed fashion e-commerce platform will use the $24.2m it has raised to grow internationally and boost its technology and product development.
Routhier finds route to Stanley Ventures president role
GCV’s top Emerging Leader in 2021, Dina Routhier, has ascended to lead the tool manufacturer’s corporate venturing efforts.
Sood sorts out Bertelsmann promotion
Rohit Sood has been made a partner for the media conglomerate’s India-based corporate venture capital unit after nine years as a principal.
Uisee drives itself to $154m
The Chinese government’s National Manufacturing Transformation and Upgrade Fund took part in a $154m round for the Robert Bosch-backed driverless car technology producer.
VSPN champions $60m round
Nan Fung Group has backed the esports tournament operator’s series B-plus round, which will go toward product development and global expansion.
Trovata treasures $20m series A
Wells Fargo Strategic Capital led the financial analysis software provider’s latest ound, investing alongside backers including Capital One Ventures.
Make Essense makes up series B round
SIG and Hupu have returned to take part in a $23.2m round for the men’s cosmetics provider, having respectively backed its series A and A-plus rounds last year.
Elinvar covets fresh funding
FinLeap and Talanx Ampega have returned to back a $30.4m round for their joint venture, which helps wealth managers digitalise business processes.
Boston Scientific takes care of $925m Preventice acquisition
The medical equipment maker is set to pay as much as $925m to buy its portfolio company that will enable Novo, Merck & Co and Samsung to exit.